Eris Lifesciences Draws Down ₹64.4 Cr Working Capital Loan

Eris Lifesciences Ltd has drawn down a working capital term loan of ₹64,40,00,000/- from Axis Bank Limited. The purpose of this loan is to meet other short-term liabilities. The company stated that its aggregate debt level will remain unchanged following this transaction. The loan agreement details, including parties, purpose, size, and terms, have been disclosed as per SEBI regulations. The loan is a working capital term loan, and the sanction letter was executed on August 5, 2026. The bank will hold a second charge on assets already created for existing working capital facilities.